Deubiquitinase OTUB1 regulates doxorubicin-induced cardiotoxicity via deubiquitinating c-MYC
Authors:
- 21 October 2023
- journal article
- research article
- Published by Elsevier in Cellular Signalling
- Vol. 113, 110937
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Wnt signaling pathway in cardiac fibrosis: New insights and directionsMetabolism, 2016
- A simple practice guide for dose conversion between animals and humanJournal of Basic and Clinical Pharmacy, 2016
- OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistanceOncogene, 2015
- Resveratrol protects against doxorubicin‐induced cardiotoxicity in aged hearts through the SIRT1‐USP7 axisThe Journal of Physiology, 2015
- Prevention of Anthracycline-Induced CardiotoxicityJACC, 2014
- Ferritin heavy chain as main mediator of preventive effect of metformin against mitochondrial damage induced by doxorubicin in cardiomyocytesFree Radical Biology and Medicine, 2014
- The mechanism of OTUB1-mediated inhibition of ubiquitinationNature, 2012
- Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1The EMBO Journal, 2011
- OTU Domain-containing Ubiquitin Aldehyde-binding Protein 1 (OTUB1) Deubiquitinates Estrogen Receptor (ER) α and Affects ERα Transcriptional ActivityJournal of Biological Chemistry, 2009
- Human pharmacokinetic characterization and in vitro study of the interaction between doxorubicin and paclitaxel in patients with breast cancer.Journal of Clinical Oncology, 1997